Sciencast Management’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.38M Buy
+88,361
New +$1.65M 0.31% 107
2021
Q4
Sell
-18,967
Closed -$260K 646
2021
Q3
$260K Sell
18,967
-6,149
-24% -$99.3K 0.07% 306
2021
Q2
$457K Buy
25,116
+8,927
+55% +$150K 0.1% 295
2021
Q1
$249K Buy
+16,189
New +$259K 0.05% 426
2019
Q2
Sell
-39,800
Closed -$385K 503
2019
Q1
$385K Buy
+39,800
New +$440K 0.14% 234
2018
Q3
Sell
-19,774
Closed -$237K 397
2018
Q2
$237K Buy
+19,774
New +$244K 0.22% 200
2017
Q1
Sell
-10,100
Closed -$103K 428
2016
Q4
$103K Buy
+10,100
New +$115K 0.14% 193

Other funds holding MDRX

Sciencast Management's MDRX Position: Q2 2022 in Review

Sciencast Management opened a new position in Veradigm Inc. Common Stock (MDRX) in Q2 2022: 88,361 shares worth $1.38M. The stake represents 0.31% of the portfolio and ranks #107 among its holdings. This is a return to the name: Sciencast Management previously reported a position in MDRX as recently as Q3 2021.

Sciencast Management first reported a position in MDRX in Q4 2016 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold MDRX as of Q2 2022.

  • Sciencast Management held 88,361 shares of Veradigm Inc. Common Stock worth $1.38M as of Q2 2022.
  • Veradigm Inc. Common Stock was a new Sciencast Management position in Q2 2022.
  • Veradigm Inc. Common Stock made up 0.31% of Sciencast Management's portfolio in Q2 2022, its #107 holding.
  • Sciencast Management first reported a position in Veradigm Inc. Common Stock in Q4 2016 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.